about
Molecular cloning and functional characterization of a new Cap'n' collar family transcription factor Nrf3Cloning of a coproporphyrinogen oxidase promoter regulatory element binding proteinMetallothionein-1 isoforms and vimentin are direct PU.1 downstream target genes in leukemia cellsDownstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implicationsGene expression profiling identifies HOXB4 as a direct downstream target of GATA-2 in human CD34+ hematopoietic cells.Role of misfolded N-CoR mediated transcriptional deregulation of Flt3 in acute monocytic leukemia (AML)-M5 subtype.A PU.1 suppressive target gene, metallothionein 1G, inhibits retinoic acid-induced NB4 cell differentiationCurrent findings for recurring mutations in acute myeloid leukemiaEpigenetic aberrations in myeloid malignancies (Review).Identification of annexin 1 as a PU.1 target gene in leukemia cells.Positive and negative regulators of the metallothionein gene (review).Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib.Effects of albumin-bound-fatty acids on the growth of the human T lymphoblastic cell line Jurkat.Induction of β-catenin by the suppression of signal regulatory protein α1 in K562 cells.Induction of erythroid-specific genes by overexpression of GATA-2 in K562 cells.Identification of Flt3 internal tandem duplications downstream targets by high-throughput immunoblotting protein array system.Identification of tenascin-C as a key molecule determining stromal cell-dependent erythropoiesis.Primary effusion lymphoma of the pericardial cavity carrying t(1;22)(q21;q11) and t(14;17)(q32;q23).Allo-antigen stimulated CD8+ T-cells suppress NF-κB and Ets-1 DNA binding activity, and inhibit phosphorylated NF-κB p65 nuclear localization in CD4+ T-cells.Regulatory mechanism of silkworm hemocyte adhesion to organs.Appearance of apoptotic cells and granular cells in the silkworm midgut lumen during larval-pupal ecdysis.High expression of YB-1 gene in erythroid cells in patients with refractory anemia.Comparison of the antioxidant activity of albumin from various animal species.Differential gene expression profiling between wild-type and ALAS2-null erythroblasts: identification of novel heme-regulated genes.Genomic structure and regulation of a novel human gene, Klp1.Correlation of PU.1 and signal regulatory protein α1 expression in PU.1 transgenic K562 cells.Expression analyses and transcriptional regulation of mouse nucleolar spindle-associated protein gene in erythroid cells: essential role of NF-Y.Primary marginal zone lymphoma of the thymus accompanied by chromosomal anomaly 46,X,dup(X)(p11p22).Nasal and nasal-type natural killer/T-cell lymphoma.Molecular functions of SIRPα and its role in cancer.Rapid diagnosis of mixed phenotype acute leukemia after identifying a blood histogram abnormality.Autoimmune neutropenia in pregnant women causing neonatal neutropeniaA cutaneous agranular CD2- CD4+ CD56+ "lymphoma": report of two cases and review of the literatureSynergistic effect of arsenic trioxide and flt3 inhibition on cells with flt3 internal tandem duplicationIncreased expression of insulin-like growth factor i is associated with Ara-C resistance in leukemiaA case of familial thrombocytosis: possible role of altered thrombopoietin productionCan the Helicobacter pylori eradication regimen induce platelet recovery in H. pylori-negative patients with idiopathic thrombocytopenic purpura?Inverse correlation between Flt3 and PU.1 expression in acute myeloblastic leukemiasPurine-rich box-1-mediated reduced expression of CD20 alters rituximab-induced lysis of chronic lymphocytic leukemia B cellsInhibition of the MEK/MAPK signal transduction pathway strongly impairs the growth of Flt3-ITD cells
P50
Q22008805-D45D8F35-E6C4-454C-AE74-EAAFCE85E518Q22254393-EB047E7D-8640-4AC7-B2B2-E55599C2BB36Q24298666-CADB18D7-B16F-423E-84E6-D8177E078747Q24617091-B9D0858A-8FA3-47B5-B41E-98004A878EFDQ33403621-B8D12624-FDB4-40C1-9E51-137DB6240285Q34238553-907E8B74-E6B0-4B7D-879F-23E16720B5E1Q35214830-89C65042-C068-4C84-A307-3B31959BDF5DQ37932085-F991DFB9-4812-475F-87A9-FA79397BD50DQ38113973-6C98F8C3-172D-4DB3-94BF-C0749E53C06BQ38354280-FD3DD287-A634-44A0-9209-D06DD50AA2A8Q38373634-159E5D58-4199-457B-8BC6-F9AF094D7304Q38770560-32AC4BD4-5F3C-40F4-98B7-5F40FED957ACQ39464624-B8A13072-C0E9-4D6B-93CD-F83B09F7222FQ39582581-F5B8609E-3FD4-48BF-891D-40AD159403E9Q40251609-E9DFB31A-1403-4E67-BF9E-818EC30B75E8Q40256156-2A70F1FF-4EE1-4160-91F3-748C4C0BBDA5Q40298902-CA5B378A-8DE0-401C-AC47-90BDBFE937F3Q40519347-BB4ACE9A-FD82-4A3A-B25B-BDC9B9317804Q41567634-0CB3EFAE-202E-4052-A190-011C08334E3CQ42017021-D00471C3-4A0E-4D4B-BE83-9B96784F9DE1Q42029012-618E7C68-22E4-4611-A07B-B564BA5F5B00Q44646276-61686187-3C45-4CA7-BEE4-D7ABB7FDE298Q46178936-E347EDEF-0B3C-4BA6-ABF3-269281138E24Q46852433-D89D7E2F-7339-43F7-884A-38A87C691D2EQ48325027-F27FE7D6-A377-4709-9B4D-6E84AE8C300EQ53206704-2977EC1E-CB7C-4120-8395-8F064C1F6F3FQ53592422-4FF0F3B1-225D-4869-9DF9-7E47305B6DEAQ53875808-5FA9C8B7-81B1-4CF2-8B69-E51AA8DF0F6EQ54104837-6357A3CA-9493-4686-AB33-6CA670CA34D6Q55315474-AF9964B8-D410-4DC1-9B54-6B5FDB0816CCQ55686218-051A4A9F-DA7F-4E11-96A1-89AA99F53A6DQ74263408-04219874-9F55-4323-8A3A-0D406385676BQ77378597-4430C64C-6929-4244-8F75-4178360D22E2Q79270328-A9BD1B90-EEBD-4FE3-8A47-70F35C9ED295Q79734958-9C29D321-4CE7-404A-BD2B-16E8EDE8FC0CQ80392769-96639512-F491-420C-90B7-D97A1A6431D6Q81342768-02143C49-3C3D-42EC-AB95-5DBACE8D4DC3Q81446053-DB870C85-DC3F-4EDC-9A03-A45680B6C535Q81969907-D7977A7F-51C3-4A38-8090-B7D14CD4920EQ82353049-7ED8F478-A2E5-4786-98E4-7182082200F0
P50
description
Japanese medical researcher
@en
name
Shinichiro Takahashi
@en
Takahashi S
@nl
type
label
Shinichiro Takahashi
@en
Takahashi S
@nl
altLabel
Takahashi S
@en
prefLabel
Shinichiro Takahashi
@en
Takahashi S
@nl
P106
P31
P496
0000-0003-0011-6065